A

Axsome Therapeutics

Biopharmaceutical company developing CNS disorder therapies

Associate Director/Director - Payer Marketing

Product MarketingConfirmed live in the last 24 hours
Full-timeNew York, NY, USAHybrid

About the Job

Requirements

  • A bachelor's degree in science, business, accounting, finance, mathematics, or a related field is required.
  • Eight to twelve years of pharmaceutical industry-related experience is required.
  • Six to ten years of experience in payer marketing, government affairs, PBM/health plan work, or other market access activities is required.
  • Ability to work onsite Monday, Tuesday, and Thursday is required; fully remote arrangements are not considered.
  • A deep understanding of the U.S. healthcare market, including reimbursement, payment models, and legal and compliance requirements, is required.
  • A strong understanding of the payer landscape and how payer decision-making affects providers and patients is required.
  • Project management experience is required.
  • Ability to influence internal and external stakeholders is required.
  • Ability to use numbers and data to communicate a story, influence decision-makers, and explain complex concepts clearly to varied audiences is required.
  • Familiarity with the current legal and regulatory landscape relevant to the industry is required.

Responsibilities

  • Support development of access and pricing strategies, particularly by interpreting and quantifying the impact of proposed and implemented legislation, political actions, and PBM and payer initiatives.
  • Monitor and interpret federal and state healthcare policy developments, including CMS guidance, Medicare Part D rules, Medicaid coverage standards, and commercial market regulations, to assess implications for payer access and affordability strategy.
  • Translate complex policy and regulatory changes into strategic guidance for payer marketing, brand teams, and senior leadership, working closely with the Executive Director.
  • Partner with market access, legal, compliance, and government affairs teams to ensure payer strategies and materials align with current and emerging policy requirements.
  • Evaluate how policy changes, including utilization management rules, inflation rebates, IRA provisions, and coverage mandates, affect formulary positioning, access barriers, and payer decision-making.
  • Integrate policy-driven insights into payer value propositions and account-specific strategies across Medicare, Medicaid, and commercial segments.
  • Support scenario planning and forecasting by assessing downstream impacts of policy shifts on access timelines, contracting leverage, and payer behavior.
  • Develop internal education and training resources to improve cross-functional understanding of policy-driven access dynamics.
  • Contribute to strategic planning for launches, loss-of-exclusivity planning, and lifecycle management by incorporating policy uncertainty and payer response models.
  • Partner with the HEOR team to deliver payer value messaging substantiated by real-world evidence generation and synthesis.
  • Manage multiple projects efficiently, securing cross-functional buy-in across different indications and therapeutic areas.

Desired Qualifications

  • An MBA is preferred.
  • Previous product launch experience is preferred, particularly in the CNS space.
  • Problem-solving ability and demonstrated critical thinking are valued.
  • Intellectual curiosity and interest in how clinical trial data and real-world evidence inform payer decision-making are valued.
  • Strong oral, written, and presentation skills are valued.

About the Company

Axsome Therapeutics

Biopharmaceutical company developing CNS disorder therapies

Axsome Therapeutics develops therapies for central nervous system disorders. Its focus is on research, development, and commercialization of treatments for conditions such as major depressive disorder, treatment-resistant depression, Alzheimer's agitation, migraine, narcolepsy, fibromyalgia, and smoking cessation. The flagship product candidate, AXS-05, is an oral NMDA receptor antagonist intended to treat MDD and TRD; it works by blocking NMDA receptors to influence brain signaling involved in mood and depression, and has received FDA Breakthrough Therapy Designation. The company earns revenue from the commercialization of its drugs, partnerships, and potential licensing deals as its pipeline progresses through clinical trials and regulatory approvals. Axsome aims to provide effective CNS therapies, advance its drug pipeline, and improve patient outcomes and quality of life.

Company size
501-1,000
Company stage
IPO
Headquarters
New York City, New York
Founded
2012

Recently Posted Jobs

Explore more opportunities at Axsome Therapeutics

See more jobs